These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 16186470)
1. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Cosgrove SE; Perl TM; Song X; Sisson SD Arch Intern Med; 2005 Sep; 165(17):2002-6. PubMed ID: 16186470 [TBL] [Abstract][Full Text] [Related]
2. Recognition and management of bioterrorism infections. O'Brien KK; Higdon ML; Halverson JJ Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654 [TBL] [Abstract][Full Text] [Related]
3. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents. Guarner J; Zaki SR J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309 [TBL] [Abstract][Full Text] [Related]
4. Clinical management of potential bioterrorism-related conditions. Adalja AA; Toner E; Inglesby TV N Engl J Med; 2015 Mar; 372(10):954-62. PubMed ID: 25738671 [TBL] [Abstract][Full Text] [Related]
5. Threats in bioterrorism. I: CDC category A agents. Darling RG; Catlett CL; Huebner KD; Jarrett DG Emerg Med Clin North Am; 2002 May; 20(2):273-309. PubMed ID: 12120480 [TBL] [Abstract][Full Text] [Related]
6. Physicians' understanding of the regulation of dietary supplements. Ashar BH; Rice TN; Sisson SD Arch Intern Med; 2007 May; 167(9):966-9. PubMed ID: 17502539 [TBL] [Abstract][Full Text] [Related]
7. Bioterrorism's invisible threats: heightened awareness will help nurses identify real and suspected bioterrorism. Altman GB Nurs Manage; 2002 Jan; 33(1):43, 45-7. PubMed ID: 11984331 [TBL] [Abstract][Full Text] [Related]
8. Bioterriorism: from threat to reality. Atlas RM Annu Rev Microbiol; 2002; 56():167-85. PubMed ID: 12142472 [TBL] [Abstract][Full Text] [Related]
9. Bioterrorism: class A agents and their potential presentations in immunocompromised patients. Richard JL; Grimes DE Clin J Oncol Nurs; 2008 Apr; 12(2):295-302. PubMed ID: 18390465 [TBL] [Abstract][Full Text] [Related]
10. Molecular diagnostic techniques for use in response to bioterrorism. Firmani MA; Broussard LA Expert Rev Mol Diagn; 2003 Sep; 3(5):605-16. PubMed ID: 14510181 [TBL] [Abstract][Full Text] [Related]
11. Recognition of illness associated with the intentional release of a biologic agent. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):893-7. PubMed ID: 11686473 [TBL] [Abstract][Full Text] [Related]
12. Management of patients exposed to biologic weapons. Yetman RJ; Parks D; Taft E J Pediatr Health Care; 2002; 16(5):256-61. PubMed ID: 12226595 [No Abstract] [Full Text] [Related]
13. Evaluation of an online bioterrorism continuing medical education course. Casebeer L; Andolsek K; Abdolrasulnia M; Green J; Weissman N; Pryor E; Zheng S; Terndrup T J Contin Educ Health Prof; 2006; 26(2):137-44. PubMed ID: 16802314 [TBL] [Abstract][Full Text] [Related]
14. Infectious agents of bioterrorism: a review for emergency physicians. Kman NE; Nelson RN Emerg Med Clin North Am; 2008 May; 26(2):517-47, x-xi. PubMed ID: 18406986 [TBL] [Abstract][Full Text] [Related]
15. Biological and chemical terrorism: recognition and management. Noeller TP Cleve Clin J Med; 2001 Dec; 68(12):1001-2, 1004-9, 1013-6. PubMed ID: 11765118 [TBL] [Abstract][Full Text] [Related]